02/07/2025
We are excited to share an update on the progress our 2024 Gayle Brinkenhoff IGNITE Awardee, Aditi Hazra, PhD, MPH has made on her IGNITE-funded research. Dr. Hazra studies Ductal Carcinoma in situ (DCIS), a form of breast cancer that starts and stays in the milk-ducts and often has worse outcomes in young women and women of color. With her INCLUDE (IN situ Carcinoma - LobUlar and Ductal - and Equity Study) Study, Dr. Hazra is working to improve DCIS outcomes in these understudied groups through community engagement and AI research. To achieve this, her team has partnered with AfroPink, Inc., a non profit that increases breast cancer awareness in the African-American community and whose founder is pictured below with Dr. Hazra, and local community leaders in the Haitian American community and the Pink and Black Boston Advocacy group. With the help of these partnerships, Dr. Hazra’s team is planning the work of collecting tissue samples from Black women and other underrepresented groups that can be used, with the help of AI, to create an algorithm that better predicts DCIS outcomes. We’re thrilled to see Dr. Hazra’s important work progress and look forward to more exciting developments!